RBC Capital upgraded Fisher & Paykel Healthcare to Sector Perform from Underperform with a price target of NZ$36, up from NZ$31. The firm cites the company’s better guidance for the upgrade.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FSPKF:
- Fisher & Paykel Healthcare Lifts FY26 Guidance as Hospital Demand and Margins Improve
- Fisher & Paykel Healthcare Discloses Shareholding of New Director Anna Curzon
- Pinnacle Investment Management Takes 5% Stake in Fisher & Paykel Healthcare
- Fisher & Paykel Healthcare strengthens board with tech and health-sector appointments
- Fisher & Paykel Healthcare Corrects Director Shareholding Disclosure